MMP2 and ST Elevation Myocardial Infarction: Additionally, in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention, higher plasma MMP-2-levels at baseline were associated with increased myocardial infarct size and decreased left ventricular function after four months of follow-up [29].